Sfoglia per Autore
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study
2021-01-01 Mariateresa Camerino, Davide Giacobino, Selina Iussich, Ugo Ala, Federica Riccardo, Federica Cavallo, Marina Martano, Emanuela Morello, Paolo Buracco
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer
2021-01-01 Ruiu R.; Barutello G.; Arigoni M.; Riccardo F.; Conti L.; Peppino G.; Annaratone L.; Marchio C.; Mengozzi G.; Calogero R.A.; Cavallo F.; Quaglino E.
The Amot/integrin protein complex transmits mechanical forces required for vascular expansion
2021-01-01 Zhang Y.; Zhang Y.; Kameishi S.; Barutello G.; Zheng Y.; Tobin N.P.; Nicosia J.; Hennig K.; Chiu D.K.-C.; Balland M.; Barker T.H.; Cavallo F.; Holmgren L.
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity
2021-01-01 Seclì, Laura; Avalle, Lidia; Poggio, Pietro; Fragale, Giuseppe; Cannata, Cristiana; Conti, Laura; Iannucci, Andrea; Carrà, Giovanna; Rubinetto, Cristina; Miniscalco, Barbara; Hirsch, Emilio; Poli, Valeria; Morotti, Alessandro; De Andrea, Marco; Turco, Emilia; Cavallo, Federica; Fusella, Federica; Brancaccio, Mara
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
2021-01-01 Salemme V.; Centonze G.; Cavallo F.; Defilippi P.; Conti L.
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases
2021-01-01 Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P.
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy
2021-01-01 Waldhauer I.; Gonzalez-Nicolini V.; Freimoser-Grundschober A.; Nayak T.K.; Fahrni L.; Hosse R.J.; Gerrits D.; Geven E.J.W.; Sam J.; Lang S.; Bommer E.; Steinhart V.; Husar E.; Colombetti S.; Van Puijenbroek E.; Neubauer M.; Cline J.M.; Garg P.K.; Dugan G.; Cavallo F.; Acuna G.; Charo J.; Teichgraber V.; Evers S.; Boerman O.C.; Bacac M.; Moessner E.; Umana P.; Klein C.
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota
2020-01-01 Di Lorenzo A.; Bolli E.; Tarone L.; Cavallo F.; Conti L.
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas
2020-01-01 Riccardo F.; Barutello G.; Petito A.; Tarone L.; Conti L.; Arigoni M.; Musiu C.; Izzo S.; Volante M.; Longo D.L.; Merighi I.F.; Papotti M.; Cavallo F.; Quaglino E.
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression
2020-01-01 Quirico L.; Orso F.; Esposito C.L.; Bertone S.; Coppo R.; Conti L.; Catuogno S.; Cavallo F.; Franciscis V.; Taverna D.
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
2020-01-01 Caldeira, Jerri C; Perrine, Michael; Pericle, Federica; Cavallo, Federica
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer
2020-01-01 Rolih V.; Caldeira J.; Bolli E.; Salameh A.; Conti L.; Barutello G.; Riccardo F.; Magri J.; Lamolinara A.; Parra K.; Valenzuela P.; Francia G.; Iezzi M.; Pericle F.; Cavallo F.
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis
2020-01-01 Avalle L.; Marino F.; Camporeale A.; Guglielmi C.; Viavattene D.; Bandini S.; Conti L.; Cimino J.; Forni M.; Zanini C.; Ghigo A.; Bogorad R.L.; Cavallo F.; Provero P.; Koteliansky V.; Poli V.
Cancer stem cell antigens as targets for new combined anti-cancer therapies
2020-01-01 Quaglino E.; Cavallo F.; Conti L.
Breast cancer stem cell antigens as targets for immunotherapy
2020-01-01 Quaglino E.; Conti L.; Cavallo F.
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2020-01-01 Conti L.; Bolli E.; Di Lorenzo A.; Franceschi V.; Macchi F.; Riccardo F.; Ruiu R.; Russo L.; Quaglino E.; Donofrio G.; Cavallo F.
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential
2020-01-01 Anemone A.; Consolino L.; Conti L.; Irrera P.; Hsu Myriam; Villano D.; Dastru W.; Porporato P.E.; Cavallo F.; Longo D.L.
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy
2019-01-01 Tarone L.; Barutello G.; Iussich S.; Giacobino D.; Quaglino E.; Buracco P.; Cavallo F.; Riccardo F.
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
2019-01-01 Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L.
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
2019-01-01 Riccardo F, Tarone L, Iussich S, Giacobino D, Arigoni M, Sammartano F, Morello E, Martano M, Gattino F, De Maria R., Ferrone S, Buracco P, Cavallo F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study | 2021 | Mariateresa Camerino, Davide Giacobino, Selina Iussich, Ugo Ala, Federica Riccardo, Federica Cavallo, Marina Martano, Emanuela Morello, Paolo Buracco | |
| Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer | 2021 | Ruiu R.; Barutello G.; Arigoni M.; Riccardo F.; Conti L.; Peppino G.; Annaratone L.; Marchio C.; Mengozzi G.; Calogero R.A.; Cavallo F.; Quaglino E. | |
| The Amot/integrin protein complex transmits mechanical forces required for vascular expansion | 2021 | Zhang Y.; Zhang Y.; Kameishi S.; Barutello G.; Zheng Y.; Tobin N.P.; Nicosia J.; Hennig K.; Chiu D.K.-C.; Balland M.; Barker T.H.; Cavallo F.; Holmgren L. | |
| Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity | 2021 | Seclì, Laura; Avalle, Lidia; Poggio, Pietro; Fragale, Giuseppe; Cannata, Cristiana; Conti, Laura; Iannucci, Andrea; Carrà, Giovanna; Rubinetto, Cristina; Miniscalco, Barbara; Hirsch, Emilio; Poli, Valeria; Morotti, Alessandro; De Andrea, Marco; Turco, Emilia; Cavallo, Federica; Fusella, Federica; Brancaccio, Mara | |
| The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy | 2021 | Salemme V.; Centonze G.; Cavallo F.; Defilippi P.; Conti L. | |
| Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases | 2021 | Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P. | |
| Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy | 2021 | Waldhauer I.; Gonzalez-Nicolini V.; Freimoser-Grundschober A.; Nayak T.K.; Fahrni L.; Hosse R.J.; Gerrits D.; Geven E.J.W.; Sam J.; Lang S.; Bommer E.; Steinhart V.; Husar E.; Colombetti S.; Van Puijenbroek E.; Neubauer M.; Cline J.M.; Garg P.K.; Dugan G.; Cavallo F.; Acuna G.; Charo J.; Teichgraber V.; Evers S.; Boerman O.C.; Bacac M.; Moessner E.; Umana P.; Klein C. | |
| Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota | 2020 | Di Lorenzo A.; Bolli E.; Tarone L.; Cavallo F.; Conti L. | |
| Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas | 2020 | Riccardo F.; Barutello G.; Petito A.; Tarone L.; Conti L.; Arigoni M.; Musiu C.; Izzo S.; Volante M.; Longo D.L.; Merighi I.F.; Papotti M.; Cavallo F.; Quaglino E. | |
| Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression | 2020 | Quirico L.; Orso F.; Esposito C.L.; Bertone S.; Coppo R.; Conti L.; Catuogno S.; Cavallo F.; Franciscis V.; Taverna D. | |
| Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines | 2020 | Caldeira, Jerri C; Perrine, Michael; Pericle, Federica; Cavallo, Federica | |
| Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer | 2020 | Rolih V.; Caldeira J.; Bolli E.; Salameh A.; Conti L.; Barutello G.; Riccardo F.; Magri J.; Lamolinara A.; Parra K.; Valenzuela P.; Francia G.; Iezzi M.; Pericle F.; Cavallo F. | |
| Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis | 2020 | Avalle L.; Marino F.; Camporeale A.; Guglielmi C.; Viavattene D.; Bandini S.; Conti L.; Cimino J.; Forni M.; Zanini C.; Ghigo A.; Bogorad R.L.; Cavallo F.; Provero P.; Koteliansky V.; Poli V. | |
| Cancer stem cell antigens as targets for new combined anti-cancer therapies | 2020 | Quaglino E.; Cavallo F.; Conti L. | |
| Breast cancer stem cell antigens as targets for immunotherapy | 2020 | Quaglino E.; Conti L.; Cavallo F. | |
| Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer | 2020 | Conti L.; Bolli E.; Di Lorenzo A.; Franceschi V.; Macchi F.; Riccardo F.; Ruiu R.; Russo L.; Quaglino E.; Donofrio G.; Cavallo F. | |
| Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential | 2020 | Anemone A.; Consolino L.; Conti L.; Irrera P.; Hsu Myriam; Villano D.; Dastru W.; Porporato P.E.; Cavallo F.; Longo D.L. | |
| Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy | 2019 | Tarone L.; Barutello G.; Iussich S.; Giacobino D.; Quaglino E.; Buracco P.; Cavallo F.; Riccardo F. | |
| Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source | 2019 | Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L. | |
| Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma | 2019 | Riccardo F, Tarone L, Iussich S, Giacobino D, Arigoni M, Sammartano F, Morello E, Martano M, Gattino F, De Maria R., Ferrone S, Buracco P, Cavallo F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile